1 week ago
Clearmind Medicine (CMND) Stock Doubles as CMND-100 Passes Critical Safety Milestone
Clearmind Medicine (CMND) stock doubled after CMND-100 achieved its primary safety endpoint in a Phase I/IIa AUD trial with no serious adverse events reported.
The post Clearmind Medicine (CMND) Stock Doubles as CMND-100 Passes Critical Safety Milestone appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
SanDisk (SNDK) Stock Declines 5% After Stellar Q3 Earnings Report
- 1 hour ago
Western Digital (WDC) Stock Surges 5% on Record Q3 Performance and Strong Cloud...
- 1 hour ago
Apple (AAPL) Stock Surges 3% on Strong Earnings and Exceptional Forward Guidance
- 1 hour ago
GoDaddy (GDDY) Stock Surges 4% After Strong Q1 Earnings and AI Platform Success
- 1 hour ago
SanDisk (SNDK) Shares Dip Despite Strong Q3 as Seagate (STX) and Western Digital...